20
Mylan Laboratories Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SODIUM NITROPRUSSIDE USP, with a corresponding US DMF Number 30849.
Remarkably, this DMF maintains an Active status since its submission on September 13, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 22, 2016, and payment made on August 29, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II